Free Trial

Tilray Brands (NASDAQ:TLRY) Trading Down 5.6% - Here's Why

Tilray Brands logo with Medical background

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report)'s share price traded down 5.6% during mid-day trading on Wednesday . The company traded as low as $0.75 and last traded at $0.74. 34,229,559 shares were traded during trading, an increase of 8% from the average session volume of 31,678,063 shares. The stock had previously closed at $0.79.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Roth Capital reiterated a "neutral" rating on shares of Tilray Brands in a research report on Monday, April 14th. Piper Sandler decreased their price target on shares of Tilray Brands from $2.00 to $1.00 and set a "neutral" rating for the company in a research note on Wednesday, April 9th. Finally, Wall Street Zen lowered shares of Tilray Brands to a "strong sell" rating in a research note on Saturday, July 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $1.92.

Read Our Latest Stock Report on TLRY

Tilray Brands Stock Performance

The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.61 and a current ratio of 2.62. The stock has a market cap of $705.56 million, a P/E ratio of -0.67 and a beta of 1.82. The company's 50 day moving average price is $0.48 and its 200-day moving average price is $0.67.

Institutional Investors Weigh In On Tilray Brands

A number of institutional investors and hedge funds have recently modified their holdings of TLRY. Lido Advisors LLC bought a new position in shares of Tilray Brands in the fourth quarter worth approximately $28,000. Cerity Partners LLC bought a new position in shares of Tilray Brands in the first quarter worth approximately $31,000. Capital Management Associates Inc raised its stake in shares of Tilray Brands by 100.0% during the first quarter. Capital Management Associates Inc now owns 50,760 shares of the company's stock worth $33,000 after acquiring an additional 25,380 shares in the last quarter. Fifth Lane Capital LP raised its stake in shares of Tilray Brands by 400.0% during the first quarter. Fifth Lane Capital LP now owns 50,000 shares of the company's stock worth $33,000 after acquiring an additional 40,000 shares in the last quarter. Finally, Zuckerman Investment Group LLC purchased a new position in shares of Tilray Brands during the first quarter worth approximately $33,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Brands Company Profile

(Get Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

Recommended Stories

Should You Invest $1,000 in Tilray Brands Right Now?

Before you consider Tilray Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.

While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines